Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EGFR EDV PLK by ImmunityBio for Malignant Mesothelioma: Likelihood of Approval
EGFR EDV PLK is under clinical development by ImmunityBio and currently in Phase I for Malignant Mesothelioma. According to GlobalData,...
Data Insights
EGFR EDV PLK by ImmunityBio for Non-Small Cell Lung Cancer: Likelihood of Approval
EGFR EDV PLK is under clinical development by ImmunityBio and currently in Phase I for Non-Small Cell Lung Cancer. According...